Please enter the email address you used to register, then we will send you a link to choose a new password
HC Wainwright & Co. analyst Andrew S. Fein assumes MetaVia (NASDAQ:MTVA) with a Buy rating and announces Price Target of...
MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16...
Partnership Leverages Syntekabio's DeepMatcher® Platform to Expand the Therapeutic Potential ofMetaVia's Oral GPR119 Ag...
Top-Line Data Expected in the Fourth Quarter of 2025CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (NASDAQ:MTVA), ...
-SEC Filing
https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05222025_MTVA_Bautz.pdf
Maxim Group analyst Jason McCarthy maintains MetaVia (NASDAQ:MTVA) with a Buy and lowers the price target from $6 to $3.
MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.51) by 29...